Choroideremia Research
Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.
Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to choroideremia, please contact us at 214-363-3911.

Related Articles
Gene Therapy Trial at the Retina Foundation of the Southwest featured in The Dallas Morning News iPad Game Study: Frequently Asked Questions Introducing the Vision and Neurodevelopment Laboratory Recently@Retina Newsletter September 2023 Three Patents Awarded for Retina Foundation’s Two-Layer Ocular Implant in Japan, Europe and the United States